We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.

After a strong performance in 2025, CVS Health has dealt with two major problems this year. First, the U.S. Centers for ...

Drug stocks can be somewhat volatile. Things like clinical setbacks or patent cliffs can sink their stock prices or erode ...

Part of Greece's plan to upgrade its military capabilities just cleared a major hurdle.

If you're a serious online shopper, there's only one credit card you have to look into. Here's how you can save 5% on online ...

These three companies, most of which you've probably never heard of, could turn a diversified investment into a seven-figure ...

Brent crude prices topped $100 this week, and WTI almost did. Oil prices drive gasoline prices -- and much, much more. Oil ...

Investors look to precious metals like gold and silver to hedge against inflation, but they aren't equally good choices.

Kadensa Capital reported a new $16.5 million position in MP stock in Q3 2025. MP Materials reported an earnings beat in Q4.

Broadcom is benefiting from the rise in AI networking and has a huge opportunity with custom AI chips. Arista Networks is a ...

Abivax and Nektar Therapeutics are clinical-stage biotech companies that would make attractive buyout targets.

The LendingClub LevelUp Savings account earns a top APY with no fees, no minimums, and easy setup. Here's how one simple ...